Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

SARS-CoV-2 antigen tests used at the point-of-care, such as the Abbott Panbio, have great potential to help combat the COVID-19 pandemic. The Panbio is Health Canada approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of COVID-19 symptom onset(s). Symptomatic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Clin Microbiol Infect Dis
Autori principali: Stokes, William, Berenger, Byron M., Portnoy, Danielle, Scott, Brittney, Szelewicki, Jonas, Singh, Takshveer, Venner, Allison A., Turnbull, LeeAnn, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Guttridge, Tracy, Proctor, Dustin, Hu, Jia, Tipples, Graham
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979467/
https://ncbi.nlm.nih.gov/pubmed/33742322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-021-04202-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi